Lee, S. M. and Schulz, C. and Prabhash, K. and Han, B. and Szczesna, A. and Cortinovis, D. L. and Rittmeyer, A. and Vicente Baz, D. and Califano, R. and Anh, L. Tuan and Liu, G. and Cappuzzo, F. and Reyes Contreras, J. G. and Reck, M. and Hu, Y. and Morris, S. and Hoeglander, E. K. and Connors, M. and Vollan, H. K. M. and Peters, S. (2022) IPSOS: Results from a phase III study of first-line (1L) atezolizumab (atezo) vs single-agent chemotherapy (chemo) in patients (pts) with NSCLC not eligible for a platinum-containing regimen. ANNALS OF ONCOLOGY, 33 (Suppl7). S1418-S1419. ISSN 0923-7534, 1569-8041
Full text not available from this repository.
Official URL: https://www.sciencedirect.com/science/article/pii/...
| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Petra Gürster |
| Date Deposited: | 04 Jul 2024 10:15 |
| Last Modified: | 04 Jul 2024 10:15 |
| URI: | https://pred.uni-regensburg.de/id/eprint/58694 |
Actions (login required)
 |
View Item |
